Top 10 Key Players Transforming the Classical Swine Fever Vaccines Market According to a newly published market research report by 24LifeSciences, global classical swine fever vaccines market was valued at USD 153 million in 2024 and is projected to reach USD 214 million by 2032, growing at a compound annual growth rate (CAGR) of 5.0% during the forecast period 2025–2032. Classical swine fever vaccines are biological preparations used to protect pigs against the highly contagious classical swine fever virus (CSFV), which belongs to the Pestivirus genus. These vaccines play a critical role in preventing disease outbreaks that can decimate swine populations and disrupt pork supply chains globally. The vaccine types primarily include live attenuated vaccines, inactivated vaccines, and newer subunit vaccines, with tissue culture origin vaccines currently dominating the market with approximately 66% share. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/1606/classical-swine-fever-vaccines-market